Brawn Biotech Ltd — Board Meeting, 26-05-2025: Board Meeting

Brawn Biotech Ltd. has announced a board meeting on which approved the audited financial results for the quarter and financial year ended March 31, 2025. The company reported a net loss for the year of ₹184.42 lakh, continuing a loss trend from previous quarters. Total revenue for the year stood at ₹1,538.05 lakh, with expenses outpacing income leading to operating losses. The balance sheet shows total assets of ₹204.88 crore, with equity at ₹33.62 crore and higher non-current liabilities at ₹78.00 crore. Cash flow from operations remained negative, and net cash levels decreased marginally. The audit was completed without qualifications, confirming the financials present a true and fair view. This reflects ongoing challenges in profitability but stable asset base, relevant for shareholders monitoring operational and financial health.